Summary
Serum growth hormone values in 37 patients with diabetic ketoacidosis were 5.4±0.8 ng/ml (S.E.M.) in males and 6.7±1.1 ng/ml in females before treatment; while in five hyperosmolar non-ketotic patients the HGH concentration was 3.9±0.5 ng/ml. One hour after insulin 90% of patients showed a rise in HGH, to a mean of 33.7±9.8 ng/ml for males and 25.5±6.0 ng/ml for females in ketoacidosis; and to 27.1±9.9 ng/ml for hyperosmolar coma patients. The rise, which was transient, was inversely correlated with pretreatment plasma glucose, the l h plasma glucose concentration and plasma urea, and directly proportional to the % fall in blood glucose after 1 h. When the ketoacidosis patients were divided into two groups according to HGH response, those with a small response had the greater disturbances of plasma glucose, blood ketone bodies, blood lactate, plasma urea, blood pH, and blood pressure, the smaller 1 h fall in blood glucose, and the higher mortality. Thus the most severely ketoacidotic patients had the poorest growth hormone response. Growth hormone is probably of little importance as an insulin antagonist in diabetic coma.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Alberti, K.G.M.M., Hockaday, T.D.R.: Rapid blood ketone estimation in the diagnosis of diabetic ketoacidosis. Brit. med. J.1972 II, 565–568.
Assan, R., Hautecouverture, G., Guillemant, S., Dauchy, F., Protin, P., Dérot, M.: Evolution de paramètres hormonaux (glucagon, cortisol, hormone somatotrope) et énergétiques (glucose, acides gras, glycerol libre) dans dix acido-cetoses diabetiques graves traitées. Path. Biol.17, 1095–1105 (1969).
Blackard, W.G., Hull, E.W., Lopez, S.A.: Effect of lipids on growth hormone secretion in humans. J. clin. Invest.50, 1439–1443 (1971).
Boden, G., Soeldner, J.S.: A sensitive double antibody radioimmunoassay for human growth hormone (HGH): Levels of HGH following rapid tolbutamide infusion. Diabetologia3, 413–421 (1967).
Cain, J.P., Williams, G.H., Dluhy, R.G.: Glucagon stimulation of human growth hormone. J. clin. Endocr.31, 222–224 (1970).
Christensen, N.J.: Plasma noradrenaline and adrenaline in untreated diabetics, during fasting and after insulin administration. (Submitted for publication).
Cryer, P.E., Daughaday, W.H.: Diabetic ketosis. Serial plasma growth hormone concentrations during therapy. Diabetes19, 519–523 (1970).
Fain, J.N., Kovacev, V.P., Scow, R.N.: Effect of growth hormone and dexamethasone on lipolysis and metabolism in isolated fat cells of the rat. J. biol. Chem.240, 3522–3529 (1965).
Gerich, J.E., Martin, M.M., Recant, L.: Clinical and metabolic characteristics of hyperosmolar nonketotic coma. Diabetes20, 228–238 (1971).
Goodman, H.M.: Effects of growth hormone on isolated adipose tissue. Proceedings of the First International Symposium on Growth Hormone. Ed. A. Pecile and E. E. Müller, Excerpta Medica Intern. Congr. Ser.158, 153–171 (1968).
Hansen, Aa.P., Johansen, K.: Diurnal patterns of blood glucose, serum free fatty acids, insulin, glucagon and growth hormone in normal and juvenile diabetics. Diabetologia6, 27–33 (1970).
Henderson, M.J., Morgan, H.E., Park, C.R.: Regulation of glucose uptake in muscle. 5. The effect of growth hormone on glucose transport in the isolated, perfused rat heart. J. biol. Chem.236, 2157–2161 (1961).
Hockaday, T.D.R., Alberti, K.G.M.M.: Diabetic coma. Endocr. Metabol. Clin.1, 751–788 (1972).
Hohorst, H.J., Kreutz, F.H., Bücher, T.H.: Über Metabolitgehalte und Metabolitkonzentrationen in der Leber der Ratte. Biochem. Z.332, 18–46 (1959).
Imura, H., Kato, Y., Ikeda, M., Morimoto, M., Yawata, M., Fukase, M.: Increased plasma levels of growth hormone during infusion of propanalol. J. clin. Endocr.28, 1079–1081 (1968).
Irie, M., Sakuma, M., Tsushima, T., Shizume, K., Nakao, K.: Effect of nicotinic acid administration on plasma growth hormone concentrations. Proc. Soc. Exp. Biol. Med.126, 708–711 (1967).
Itaya, K., Ui, M.: Colorimetric determination of free fatty acids in biological fluids. J. Lipid Res.6, 16–20 (1965).
Jacobs, H.S., Nabarro, J.D.: Plasma 11-hydroxycorticosteroid and growth hormone levels in acute medical illnesses. Brit. Med. J.1969 II, 595–598.
Johansen, K., Hansen, Aa.P.: Diurnal serum, growth hormone in poorly and well-controlled juvenile diabetics. Diabetes20, 239–245 (1971).
Johnson, R.D., Conn, J.W., Dykman, C.J., Pek, S., Stam, J.I.: Mechanism and management of hyperosmolar coma without ketoacidosis in the diabetic. Diabetes18, 111–116 (1969).
Madison, L.L., Luft, R., Seyffert, W.A., Jr.: Acute effect of physiologic and pharmacologic doses of growth hormone on hepatic glucose output and peripheral glucose utilisation. In Protein and Polypeptide. Hormones. Ed. M. Margoulies, Excerpta Medica, Int. Cong. Ser.161, 529–538 (1969).
Nakagawa, K., Horiuchi, Y., Mashimo, K.: Responses of plasma growth hormone and corticosteroids to insulin and arginine with or without prior administration of dexamethàsme. J. clin. Endocr.29, 35–40 (1969).
Quabbé, H.J., Elban, K., Siegers, U., Bratzke, H.J.: Studies on a possible feedback mechanism between plasma fatty acid concentration and human growth hormone. Proceedings of the second International Sympolium on Growth Hormone. Excerpta Medica, Int. Congr. Ser.236, 59 (1971).
Park, C.R., Brown, D.H., Cornblath, M., Daughaday, W.H., Krahl, M.E.: The effect of growth hormone on glucose uptake by the isolated rat diaphragm. J. biol. Chem.197, 151–166 (1952).
Podolsky, S., Burrows, B.A., Pattavina, C.: Effect of chronic potassium depletion on growth hormone release in man. Proceedings of the Second International Symposium on Growth Hormone. Excerpta Medica, Int. Congr. Ser.236, 50 (1971).
Roth, J., Glick, S.M., Yalow, R.S., Berson, S.A.: Secretion of human growth hormone: Physiologic and experimental modification. Metabolism12, 577–579 (1963).
Roth, J., Glick, S.M., Yalow, R.S., Berson, S.A.: Influence of blood glucose on the plasma concentration of growth hormone. Diabetes13, 355–361 (1964).
Soeldner, J.S., Slone, D.: Critical variables in the radioimmunoassay of serum insulin using the double antibody technic. Diabetes14, 771–779 (1965).
Sönksen, P.H., Srivastava, M.C., Tompkins, C., Nabarro, J. D. N.: Growth hormone and cortisol responses to insulin infusion in patients with diabetes mellitus. Lancet1972 II, 155–160.
Unger, R.H.: High growth hormone levels in diabetic ketoacidosis. J. Amer. med. Ass.191, 945–947 (1965).
Vinik, A., Seftel, H., Joffe, B.I.: Metabolic findings in hyperosmolar, non-ketotic diabetic stupor. Lancet1970 II, 797–799.
Williamson, D.H., Mellanby, J., Krebs, H.A.: Enzymic determination of D(−)β-hydroxybutyric acid and acetoacetic acid in blood. Biochem. J.82, 90–96 (1962).
Young, F.G.: The relationship of the anterior pituitary gland to carbohydrate metabolism. Brit. Med. J.1939 II, 393–396.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Alberti, K.G., Hockaday, T.D. Diabetic coma: Serum growth hormone before and during treatment. Diabetologia 9, 13–19 (1973). https://doi.org/10.1007/BF01225994
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01225994